Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atazanavir-induced hyperbilirubinemia during human endotoxemia
NL-OMON33311Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of atazanavir in sepsis (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Circulating cytokine concentrations after LPS. Started May 2009; status: active, not recruiting.
02
Drugs
atazanavir
03
Conditions
sepsis
Beyond the preview
Go deeper on NL-OMON33311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33311.